Neural Therapeutics Inc.
NURL
CNSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -693.40K | -720.60K | -998.60K | -398.30K | -447.50K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 354.50K | 366.80K | 488.40K | 11.70K | 26.10K |
| Change in Net Operating Assets | 80.50K | 131.10K | 294.50K | 329.60K | 375.70K |
| Cash from Operations | -258.30K | -222.60K | -215.60K | -56.80K | -45.70K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 0.00 | 0.00 | 11.00K | 11.30K | 11.00K |
| Total Debt Repaid | -12.90K | -12.90K | -12.40K | -- | -- |
| Issuance of Common Stock | 518.50K | 518.50K | 573.50K | 516.40K | 55.00K |
| Repurchase of Common Stock | -53.20K | -53.20K | -- | -- | -95.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -38.50K | -38.50K | -38.50K | 0.00 | 0.00 |
| Cash from Financing | 289.90K | 289.90K | 377.20K | 373.10K | -22.30K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31.70K | 67.40K | 161.60K | 316.20K | -68.10K |